Financial insights of ABBV

MyFinsight

For the year ending 2025-12-31, ABBV made $61,160M in revenue. $4,226M in net income. Net profit margin of 6.91%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Net revenues	61,160	56,334	54,318	58,054
Cost of products sold	18,204	16,904	20,415	17,414
Selling, general and administrative	14,010	14,752	12,872	15,260
Research and development	9,096	12,791	7,675	6,510
Acquired ipr&d and milestones	5,016	2,757	778	697
Other operating income	241	7	179	-56
Total operating costs and expenses	46,085	47,197	41,561	39,937
Operating earnings	15,075	9,137	12,757	18,117
Interest expense, net	-2,627	-2,160	-1,684	-2,044
Net foreign exchange loss	-58	-21	-146	-148
Other expense, net	-5,793	-3,240	-4,677	-2,448
Earnings before income tax expense	6,597	3,716	6,250	13,477
Income tax expense (benefit)	2,364	-570	1,377	1,632
Net earnings	4,233	4,286	4,873	11,845
Net earnings attributable to noncontrolling interest	7	8	10	9
Net earnings attributable to abbvie inc	4,226	4,278	4,863	11,836

Basic earnings per share (in dollars per share)	2.37	2.4	2.73	6.65
Diluted earnings per share (in dollars per share)	2.36	2.39	2.72	6.63
Weighted-average basic shares outstanding (in shares)	1,769,000,000	1,769,000,000	1,768,000,000	1,771,000,000
Weighted-average diluted shares outstanding (in shares)	1,773,000,000	1,773,000,000	1,773,000,000	1,778,000,000